Shalby Ltd.

NSE: SHALBY BSE: 540797 SECTOR: Hospital & Healthcare Services  21k   87   8

129.95
+12.95 (11.07%)
NSE: 29 Mar 4:00 PM

Price Summary

Today's High

₹ 131.95

Today's Low

₹ 122

52 Week High

₹ 167.95

52 Week Low

₹ 94.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1403.59 Cr.

Enterprise Value

1340.47 Cr.

No. of Shares

10.8 Cr.

P/E

17.96

P/B

1.48

Face Value

₹ 10

Div. Yield

0.77 %

Book Value (TTM)

₹  88.09

CASH

104.43 Cr.

DEBT

41.31 Cr.

Promoter Holding

74.12 %

EPS (TTM)

₹  7.23

Sales Growth

54.58%

ROE

7.95 %

ROCE

11.33%

Profit Growth

62.79 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year54.58%
3 Year11.86%
5 Year14.95%

Profit Growth

1 Year62.79%
3 Year29.56%
5 Year18.12%

ROE%

1 Year7.95%
3 Year5.53%
5 Year5.72%

ROCE %

1 Year11.33%
3 Year8.5%
5 Year8.31%

Debt/Equity

0.0456

Price to Cash Flow

13.9

Interest Cover Ratio

23.729754322111

CFO/PAT (5 Yr. Avg.)

1.38840583788245

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 74.12 0
Sep 2022 74.04 0
Jun 2022 74.04 0
Mar 2022 74.02 0
Dec 2021 74.02 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.5561589793334% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 23.729754322111.
  • Company’s PEG ratio is 0.286085748333863.
  • The company has an efficient Cash Conversion Cycle of -2260.1732494387 days.
  • Company has a healthy liquidity position with current ratio of 3.6936160154564.
  • The company has a good cash flow management; CFO/PAT stands at 1.38840583788245.
  • The company has a high promoter holding of 74.12%.

 Limitations

  • The company has shown a poor revenue growth of 11.8564855228334% for the Past 3 years.
  • Company has a poor ROE of 5.52798236526337% over the past 3 years.
  • Company has contingent liabilities of 200.907 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 150.19 147.78 177.1 177.94 176.02
Total Expenditure 121.82 120.09 138.26 139.29 141.22
Operating Profit 28.37 27.69 38.85 38.65 34.8
Other Income 2.88 4.62 3.93 5.05 3.75
Interest 0.65 0.71 0.75 0.89 0.77
Depreciation 9.13 8.95 9.26 9.28 9.23
Exceptional Items -4.44 0 0 0 0
Profit Before Tax 17.03 22.65 32.77 33.54 28.56
Tax 4.4 6.97 11.31 11.73 9.36
Profit After Tax 12.63 15.68 21.46 21.8 19.2
Adjusted EPS (Rs) 1.17 1.45 2 2.03 1.79

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 380.29 462.41 483.89 418.67 647.16
Total Expenditure 300.39 378.89 401.33 331.63 515.54
Operating Profit 79.89 83.53 82.56 87.04 131.62
Other Income 9.63 9.37 17.74 9.62 12.64
Interest 12.14 9.17 7.41 4.5 4.4
Depreciation 22.43 33 35.86 36.67 35.5
Exceptional Items 0 0 0 0 -4.44
Profit Before Tax 54.96 50.73 57.03 55.49 99.92
Tax 14.49 18.62 29.06 12.61 30.11
Net Profit 40.47 32.1 27.97 42.88 69.81
Adjusted EPS (Rs.) 3.75 2.97 2.59 3.97 6.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 108.01 108.01 108.01 108.01 108.01
Total Reserves 657.25 686.02 705.78 741.64 798.71
Borrowings 75.44 56.91 48.67 35.5 25.33
Other N/C liabilities 59.29 73.39 95.89 114.47 146.44
Current liabilities 143 90.82 83.25 82.37 97.31
Total Liabilities 1042.99 1015.15 1041.6 1081.99 1175.8
Assets
Net Block 647.34 689.06 669.82 657.58 628.18
Capital WIP 46.4 1.74 3.02 3.99 4.48
Intangible WIP 0.38 1.61 3.37 3.53 1.25
Investments 8.68 10.61 10.65 11.79 36.6
Loans & Advances 95.84 101.95 110.72 120.3 143.31
Other N/C Assets 0.28 3.72 3.37 7.61 2.57
Current Assets 244.07 206.46 240.65 277.2 359.41
Total Assets 1042.99 1015.15 1041.6 1081.99 1175.8
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 54.96 50.73 57.03 55.49 99.92
Adjustment 32.18 35.74 36.82 36.75 41.29
Changes in Assets & Liabilities -60.21 -30.83 -16.75 -5.76 -17.42
Tax Paid -11.73 -10.1 -20.02 -9.24 -22.81
Operating Cash Flow 15.2 45.54 57.09 77.24 100.98
Investing Cash Flow -241.42 -0.04 -32.28 -51.83 -40.32
Financing Cash Flow 225.52 -51.26 -21.5 -27.82 -17.25
Net Cash Flow -0.7 -5.76 3.31 -2.41 43.41

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Promoters 74.02 74.02 74.04 74.04 74.12
vikram i shah - - - - -
shah family trust ... 34.73 34.73 34.73 34.73 34.73
zodiac mediquip li... 29.21 29.21 29.21 29.21 29.21
vikram indrajit sh... 7.16 7.16 7.18 7.18 7.26
darshini vikram sh... 2.79 2.79 2.79 2.79 -
darshini vikarm sh... - - - - 2.79
shanay vikram shah 0.13 0.13 0.13 0.13 0.13
kairav kirit shah - - - - -
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Investors 25.98 25.98 25.96 25.96 25.88
polus global fund 1.03 1.03 1.03 - 1.03
polum global fund - - - 1.03 -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Shalby’s arm subscribes additional stake in Shalby Global Technologies17 Mar 2023, 2:29PM Shalby’s healthcare education division signs MoU with Silver Oak University10 Mar 2023, 9:51AM Shalby informs analyst meet 28 Feb 2023, 10:45AM Shalby informs about signing of MoU17 Feb 2023, 12:29PM Shalby’s healthcare education division signs MoU with IIPH University16 Feb 2023, 5:57PM Shalby’s arm gets nod to market, sell Knee Implants, Hip Systems, Knee, Hip Instruments16 Feb 2023, 12:09PM Shalby’s arm gets nod to start business operations7 Feb 2023, 12:00PM Shalby opens orthopedic centre in Gwalior24 Jan 2023, 10:58AM Shalby reports 18% rise in Q3 consolidated net profit18 Jan 2023, 11:22AM Shalby - Quaterly Results17 Jan 2023, 5:19PM Shalby - Quaterly Results17 Jan 2023, 5:19PM Shalby - Quaterly Results17 Jan 2023, 5:19PM Shalby’s arm subscribes additional stake in Shalby Global Technologies2 Dec 2022, 5:15PM Shalby informs about disclosure2 Dec 2022, 4:37PM Shalby informs about newspaper advertisement10 Nov 2022, 5:10PM Shalby informs about appointment of additional director19 Oct 2022, 9:56AM Shalby - Quaterly Results18 Oct 2022, 5:56PM Shalby - Quaterly Results18 Oct 2022, 5:56PM Shalby informs about analyst meet 15 Oct 2022, 10:48AM Shalby informs about newspaper publication5 Sep 2022, 4:33PM Shalby informs about annual report3 Sep 2022, 1:04PM Shalby informs about AGM3 Sep 2022, 12:26PM Shalby’s arm hikes stake in SGTPL23 Aug 2022, 11:07AM Shalby’s healthcare education academy enters into partnership with HealthstaffEd28 Jul 2022, 9:58AM Shalby reports marginal fall in Q1 consolidated net profit27 Jul 2022, 12:51PM Shalby informs about conference call26 Jul 2022, 4:53PM Shalby informs about disclosure26 Jul 2022, 3:27PM Shalby - Quaterly Results26 Jul 2022, 1:45PM Shalby - Quaterly Results26 Jul 2022, 1:45PM Shalby - Quaterly Results26 Jul 2022, 1:45PM Shalby - Quaterly Results25 May 2022, 7:08PM Shalby - Quaterly Results25 May 2022, 7:08PM Shalby informs about board meeting 14 May 2022, 11:27AM Shalby’s arm subscribes additional share in Shalby Global Technologies25 Mar 2022, 4:28PM Shalby informs about investor meet14 Mar 2022, 1:16PM Shalby inaugurates Orthopedic Centre of Excellence franchise in Ahmedabad 14 Mar 2022, 11:07AM Shalby’s arm gets import license for import of medical devices 10 Feb 2022, 10:11AM Shalby informs about earnings call transcript8 Feb 2022, 12:46PM Shalby - Quaterly Results2 Feb 2022, 2:29PM Shalby - Quaterly Results2 Feb 2022, 2:29PM Shalby - Quaterly Results2 Feb 2022, 2:29PM Shalby’s arm invests $1 million in Shalby Advanced Technologies21 Jan 2022, 2:05PM Shalby informs about disclosure8 Dec 2021, 12:02PM Shalby’s arm increases stake in Singapore subsidiary company8 Dec 2021, 10:34AM Shalby informs about investor presentation2 Dec 2021, 12:35PM Shalby informs about investor presentation28 Oct 2021, 10:32AM Shalby informs about newspaper advertisement 27 Oct 2021, 4:27PM Shalby informs about upgradation of long term credit rating16 Sep 2021, 12:16PM Shalby inaugurates new hospital with 150 beds capacity in Mumbai7 Jun 2021, 9:21AM Shalby informs about annual secretarial compliance report2 Jun 2021, 12:26PM

Shalby Stock Price Analysis and Quick Research Report. Is Shalby an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Shalby and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 100.98 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Shalby has a Debt to Equity ratio of 0.0456 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Shalby , the EPS growth was 62.7934508816121 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Shalby has OPM of 20.3380925891588 % which is a good sign for profitability.
     
  • ROE: Shalby have a poor ROE of 7.94888554360921 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Shalby

X